Prostate-specific Membrane Antigen PET/CT in Nonprostatic Malignancies Potential Applications in Theranostics

Prostate-specific Membrane Antigen PET/CT in Nonprostatic Malignancies Potential Applications in Theranostics is organized by Lippincott CME Connection.

Published: June 2026
Expires: 05/31/2028

Description:
Method of Participation in the Learning Process/Evaluation Method
Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity
As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.
While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives:
After completing this continuing education activity you will be able to:

1. Assess the basics of PSMA and its mechanism of localization in prostate cancer and nonprostatic tissues.
2. Identify nonprostate malignancies showing PSMA uptake.
3. Outline benign causes of PSMA uptake and differentiate them from pathologic uptake.
4. Evaluate the clinical exploration of PSMA-based PET/ CT in the imaging of various cancers and potential therapeutic applications.

Topics: Nonprostatic Malignancies, PET/CT, Prostate Cancer, Theranostics